2017 The new Capital, page-511

Zhouxin is a premium healthcare chain headquartered in Xiamen, Fujian province, China. CITIC
Pharmaceutical is a shareholder in Zhouxin. Zhouxin is a market leader in cardiovascular MRI. Zhouxin offers
health services including healthcheck, medication, healthcare, senior care, and a health club for very high
net worth patients, called Top Boss.
Capitol will own a 30% stake in the JV contributing RMB3 million (approximately AUD$600,000), CITIC
Pharmaceutical will own 60%, Zhouxin will own 10%, and combined, will contribute RMB7 million. The
agreement also provides Capitol with an option at Capitol’s discretion to take ownership stakes in new
diagnostic imaging centers to be under management. As the JV will establish greenfield imaging centres it
is not expected to generate earnings during the FY17 period.
CAMI’s early diagnostic imaging centers are planned for opening in 2017 in cities where CITIC already own
hospitals that will generate patient referrals.
Open late 2017, earnings 2018.